SCHEMBL5202274

SCHEMBL5202274

O=c1c(-c2ccccc2-c2noc3ccccc3c2=O)noc2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.50
ESR2 Q92731 3/20 0.50
MAOA P21397 3/20 0.47
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47
CYP3A4 P08684 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
GLA P06280 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
PGAM1 P18669 1/20 0.47
CASP1 P29466 1/20 0.47
CASP7 P55210 1/20 0.47
HSD17B10 Q99714 1/20 0.47
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
LMNA P02545 1/20 0.42
CA3 P07451 1/20 0.42
CA4 P22748 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16927398 0.83 NR4A2 (0.46) ESR1ESR2MAOAKDM4EALDH1A1
SCHEMBL312058 0.78 ESR1 (0.57) ESR1ESR2MAOAKDM4EALDH1A1
SCHEMBL7323586 0.76 KDM4E (0.51) ESR1ESR2MAOAKDM4EALDH1A1
SCHEMBL14261867 0.74 ESR1 (0.72) ESR1ESR2SMN1; SMN2HPGDFFAR4
SCHEMBL28906146 0.74 KDM4E (0.48) ESR1ESR2MAOAKDM4EALDH1A1
SCHEMBL6439681 0.74 MAOA (0.48) ESR1ESR2MAOAKDM4EALDH1A1
SCHEMBL29940757 0.74 KDM4E (0.48) ESR1ESR2MAOAKDM4EALDH1A1
SCHEMBL28543077 0.73 ESR1 (0.54) ESR1ESR2MAOAALDH1A1SMN1; SMN2
SCHEMBL6711107 0.73 ESR1 (0.50) ESR1ESR2MAOACYP3A4SMN1; SMN2
SCHEMBL9035687 0.72 ESR1 (0.53) ESR1ESR2CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7176252-B2 Solid melt blended phosphite composites DOVER CHEMICAL CORPORATION (US) 2007-02-13 US disclosed
US-20040164279-A1 Solid melt blended phosphite composites WELLS FARGO BANK, NATIONAL ASSOCIATION 2004-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040164279-A1 Solid melt blended phosphite composites PHOSPHO1, MTAP, INPPL1 ESR1 3297/4885ESR2 3960/4885MAOA 2348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.